UnitedHealth Group (UNH) delivered mixed results in Q2 FY2026 on revenue of $112.0B versus the $110.8B estimate (+0.4% YoY) and EPS of $6.38. The next UnitedHealth Group (UNH) earnings date is Oct 27, 2026. Below is the full UnitedHealth Group earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.
UnitedHealth Group (UNH) Earnings Analysis — key stats
Next earnings date
Oct 27, 2026
Latest reported quarter
Q2 FY2026
Earnings verdict
Mixed
EPS beat rate
4 of last 8 (quarters above estimate)
Avg next-day move
±9.4% (over the last 8 reports)
Post-earnings direction
Up 2 / Down 6 (of the last 8 reports)
Implied move (next report)
±10.2% (options-derived · into Oct 27, 2026)
Institutional ownership
151.5% (13F as of 2026-06-30)
Top 10 holders
38.4% (of shares outstanding)
Insider activity
10 buys / 2 sells (recent Form 4 filings)
Revenue
$112.0B (vs $110.8B est · +1.1% surprise · +0.4% YoY)
EPS
$6.38 (vs $4.94 est · +29.1% surprise · +60.9% YoY)
Share price
$398.76 (+2.2%)
Market cap
$362.1B
UnitedHealth Group (UNH) Earnings Analysis — beat / miss history
Quarter
Revenue
EPS
EPS surprise
Next-day move
Verdict
Q3 FY2026
$112.0B vs $110.8B est
$6.38 vs $4.94 est
+29.1%
+1.8%
Mixed
Q2 FY2026
$112.0B vs $109.4B est
$7.23 vs $6.46 est
+11.9%
+9.3%
Beat
Q1 FY2026
$113.2B vs $113.8B est
$2.11 vs $2.10 est
+0.5%
-16.4%
In line
Q4 FY2025
$113.2B vs $113.0B est
$2.92 vs $2.80 est
+4.3%
-2.9%
Mixed
Q3 FY2025
$111.6B vs $111.5B est
$4.08 vs $4.45 est
-8.3%
-5.7%
Mixed
Q2 FY2025
$109.6B vs $111.6B est
$7.20 vs $7.29 est
-1.2%
-27.3%
In line
Q1 FY2025
$100.8B vs $101.6B est
$6.81 vs $6.74 est
+1.0%
-6.2%
In line
Q4 FY2024
$99.2B vs $99.1B est
$7.15 vs $7.00 est
+2.1%
-5.6%
Mixed
Top institutional holders
Holder
% outstanding
Shares
Value
QoQ change
Blackrock, INC.
8.4%
76.9M
$31.9B
+4.6%
Vanguard Capital Management LLC
6.5%
59.3M
$24.7B
+0.7%
State Street Corp
5.0%
45.6M
$19.0B
+0.7%
Capital World Investors
3.3%
29.9M
$12.4B
+7.6%
Fmr LLC
3.1%
28.0M
$11.6B
+132.9%
Vanguard Portfolio Management LLC
2.7%
24.5M
$10.2B
+1.9%
Price T Rowe Associates INC /Md/
2.5%
23.2M
$9.6B
+10.9%
Geode Capital Management, LLC
2.4%
21.8M
$9.0B
-4.5%
Jpmorgan Chase & CO
2.2%
20.2M
$8.5B
+6.0%
Sixth Street Partners Management Company, L.P.
2.2%
19.8M
$8.2B
+100.0%
Recent insider transactions
Insider
Role
Date
Type
Shares
Value
Stankiewicz Dennis Andrew
officer: Chief Accounting Officer
2026-08-11
Sell
233
$93872
Conway Patrick Hugh
officer: Chief Executive Officer, Optum
2026-08-05
Sell
500
$205000
Noseworthy John H
director
2026-07-01
Buy
206
—
MONTGOMERY RICE VALERIE MD
director
2026-07-01
Buy
220
—
MCNABB FREDERICK WILLIAM III
director
2026-07-01
Buy
250
—
Gottlieb Scott
director
2026-07-01
Buy
210
—
Gil Kristen
director
2026-07-01
Buy
206
—
GARCIA PAUL R
director
2026-07-01
Buy
88
—
What you'll find
Next UnitedHealth Group (UNH) earnings date, the expected move and the estimates priced in
A clear Beat / Miss / In-line / Mixed verdict the moment UnitedHealth Group reports
Revenue & EPS versus estimates, guidance and segment trends
Multi-lens price forecast — analyst, quant, technical and options views
Deep research: red flags, risk decoder and earnings-call sentiment
Technicals, options / implied volatility and unusual-activity signals
Hedge-fund and legendary-investor 13F holdings in UnitedHealth Group (UNH)
Side-by-side peer and historical earnings comparison
Frequently asked questions
When is UnitedHealth Group's next earnings date?
UnitedHealth Group's (UNH) next scheduled earnings date is Oct 27, 2026. Magnisto shows the confirmed date, the options-implied expected move and the revenue and EPS estimates Wall Street is modeling into the report.
Did UnitedHealth Group (UNH) beat or miss earnings?
In Q2 FY2026, UnitedHealth Group (UNH) posted mixed results — revenue of $112.0B versus the $110.8B estimate (+1.1% surprise) and EPS of $6.38 versus $4.94 expected (+29.1% surprise). Magnisto decodes every UnitedHealth Group (UNH) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
How often does UnitedHealth Group beat earnings estimates?
Over its last 8 reported quarters, UnitedHealth Group (UNH) beat Wall Street EPS estimates 4 times, most recently a mixed result in Q3 FY2026. Magnisto tracks every UnitedHealth Group (UNH) quarter's revenue and EPS versus consensus and grades each one Beat, Miss, In-line or Mixed at a unified ±2% threshold.
How much does UnitedHealth Group stock move after earnings?
Over its last 8 quarterly reports, UnitedHealth Group (UNH) moved an average of ±9.4% the day after earnings — ranging from -27.3% (Q2 FY2025) to +9.3% (Q2 FY2026). The stock rose after 2 of those 8 reports and fell after 6. Heading into its next report on Oct 27, 2026, options-implied volatility is pricing in a move of roughly ±10.2% (derived). Magnisto tracks the realized post-earnings move for every UnitedHealth Group (UNH) quarter alongside the beat/miss verdict — past moves don't predict the next one.
Who are the largest shareholders of UnitedHealth Group?
Institutions hold about 151.5% of UnitedHealth Group's (UNH) shares outstanding as of the 2026-06-30 13F quarter. Its largest institutional holders include Blackrock, INC. (8.4%), Vanguard Capital Management LLC (6.5%), State Street Corp (5.0%). Magnisto lists UnitedHealth Group's (UNH) top 13F holders with each stake size and its quarter-over-quarter change.
Are insiders buying or selling UnitedHealth Group (UNH)?
In the most recent Form 4 filings Magnisto tracks, UnitedHealth Group (UNH) insiders recorded 10 purchases and 2 sales — net buying. Insider transactions are one signal among many and are often routine (option exercises or scheduled 10b5-1 sales), so Magnisto shows the raw feed for you to judge.
What is the forecast for UnitedHealth Group (UNH) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for UnitedHealth Group (UNH), anchored to the current $398.76 share price, so you can weigh the bull, base and bear cases for UnitedHealth Group side by side.
Is UnitedHealth Group (UNH) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether UnitedHealth Group fits your own thesis and risk profile. This is research, not investment advice.